Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
algorithm
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, early onset
Alzheimer's disease, familial
Alzheimer's disease, familial, late onset
Alzheimer's disease, pathogenesis
Alzheimer's disease, preclinical
Alzheimer's disease, risk factors in
amyloid beta protein
apolipoprotein E
APP
APP gene
chromosomal abnormality
chromosome 1
chromosome 14
chromosome 21
dementia
dementia, differential diagnosis of
dementia, presenile
familial
gene
gene mutation
genetic counselling
genetic linkage
genetic neurologic disorders
genetic screening
genetic testing
laboratory values, normal
mitochondrial disease
molecular genetics
mongolism
myoclonus
neurofibrillary degeneration
practice guidelines
presenilin-1 gene
presenilin-2 gene
prevention of neurologic disorders
review article
risk factors
senile plaques
tau protein
tauopathy
treatment of neurologic disorder
Showing articles 50 to 100 of 1236 << Previous Next >>

In Vivo Mapping of Amyloid Toxicity in Alzheimer Disease
Neurol 72:1504-1511, Frisoni,B.G.,et al, 2009

Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Arch Neurol 65:1509-1517, Aizenstein,H.J.,et al, 2008

Assessment of �-Amyloid in a Frontal Cortical Brain Biopsy Specimen and by Positron Emission Tomography with Carbon 11-Labeled Pittsburgh Compound B
Arch Neurol 65:1304-1309,1281, Leinonen,V.,et al, 2008

Disease-Modifying Therapies for Alzheimers: New Drugs on the Horizon
Practical Neurology 7:16-23, Christensen,D.B., 2008

Phase 2 Safety Trial Targeting Amyloid � Production With a ?-Secretase Inhibitor in Alzheimer Disease
Arch Neurol 65:1031-1038, Fleisher,A.S.,et al., 2008

Long-Term Effects of A�42 Immunisation in Alzheimers Disease: Follow-Up of a Randomised, Placebo-Controlled Phase I Trial
Lancet 372:216-223,180, Holmes,C.,et al., 2008

Primary Central Nervous System Vasculitis with Prominent Leptomeningeal Enhancement
Arthritis Rheum:58:595-603, Salvarani, C.,et al, 2008

Imaging of Amyloid Burden and Distribution in Cerebral Amyloid Angiopathy
Ann Neurol 62:229-234, Johnson,K.A.,et al, 2007

Disease-Modifying Therapies for Alzheimer Disease: Challenges to Early Intervention
Neurol 69:1622-1634, Cummings,J.L.,et al, 2007

PET of Brain Amyloid and Tau in Mild Cognitive Impairment
NEJM 355:2652-2663, Small,G.W.,et al, 2006

Multiple Diagnostic Tests Are Needed to Assess Multiple Causes of Dementia
Arch Neurol 63:144-146,146, Rikkert,M.G.M.O.,et al, 2006

A-beta Vaccination Effects on Plaque Pathology in the Absence of Encephalitis in Alzheimer Disease
Neurol 64:129-131,10, Masliah,E.,et al, 2005

Amyloid Myopathy Presenting with Distal Atrophic Weakness
Muscle Nerve 29:605-609, Smestad, C.,et al, 2004

Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future
Radiology 226:315-336, Petrella,J.R.,et al, 2003

Alzheimer Disease
JAMA 287:2335-2338, Cummings,J.L. &Cole,G., 2002

Evaluation of CSf-tau and CSF-AB42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice
Arch Neurol 58:373-379,349, Andreasen,N.,et al, 2001

Clinicopath Conf,Mononeuritis Multiplex Due to Systemic Amyloidosis
NEJM 344:917-923, Case 9-2001, 2001

Clinicopath Conf,Cerebral Amyloid Angiogpathy and Giant-Cell Inflammatory Reaction to Beta 4-Amyloid and Vasculitis, Case 10-2000
NEJM 342:957-965, , 2000

Immunization for Alzheimer's Disease: A Shot in the Arm or a Whiff?
Ann Neurol 48:553-555, Levey,A.I., 2000

Amyloid Myopathy:An Underdiagnosed Entity
Ann Neurol 43:719-728, Spuler,S.,et al, 1999

New Neuropathological Criteria for Alzheimer Disease
Arch Neurol 55:1174-1176, Hyman,B.T., 1998

Prognosis of patients with Primary Systemic Amyloidosis Who Present with Dominant Neuropathy
Am J Med 104:232-237, Rajkumar,S.V.,et al, 1998

Longitudinal Study of CSF Levels of Tau, A beta 1-40, and A beta 1-42 (43) in Alzheimer's Disease
Ann Neurol 44:17-26, 61998., Kanai,M.,et al, 1998

Neuropathies Associated with Paraproteinemia
NEJM 338:1601-1607, Ropper,A.H.&Gorson,K.C., 1998

Electromagnetic Field Exposure May Cause Increased Production of Amyloid Beta & Eventually lead to Alzheimer's Disease
Neurol 47:1594-1600, Sobel,E.&Davanipour,Z., 1996

A New Variant of Creutzfeldt-Jakob Disease in the UK
Lancet 347:921-925, 915, 916, 91796., Will,R.G.,et al, 1996

The Neuropathology of Williams Syndrome
Arch Neurol 52:209-212, Golden,J.A.,et al, 1995

Clinicopath Conf
Multiple Myeloma with Bilateral Carpal Tunnel Syndrome Probably Due to Secondary Amyloid Deposit, Ca, e38-1995,NEJM 333:1625-1630,1995., 1995

Is Alzheimer's Disease an Apolipoprotein E Amyloidosis?
Lancet 345:956-958, Wisniewski,T.,et al, 1995

Image Analysis of B-Amyloid Load in Alzheimer's Disease and Relation to Dementia Severity
Lancet 346:1524-1528, Cummings,B.J.&Cotman,C.W., 1995

Apolipoprotein E, Dementia, and Cortical Deposition of B-Amyloid Protein
NEJM 333:1242-1247, 12831995., Polvikoski,T.,et al, 1995

Regional Distrib of Neurofibrillary Tangles & Senile Plaques in Cerebral Cortex of Very Old Pts
Arch Neurol 52:1150-1159, Gioannakopoulos,P.,et al, 1995

Alzheimer's-Disease-Like Changes in Tau Protein Processing:Assoc with Aluminium Accum in Brains of Dialysis Pts
Lancet 343:993-997, 9891994., Harrington,C.R.,et al, 1994

Human Prion Diseases
Ann Neurol 35:385-395, Prusiner,S.B.&Hsiao,K.K., 1994

Clinicopath Conf
Spongiform Encephalopathy (Creutzfeldt-Jakob Disease) , with Amyloid (KURU) Plaques, Case 17-1993, N, JM 328:66,1993., 1993

Amyloidoma of the CNS. I. Clinical and Pathologic Study
Neurol 42:2019-2023, Cohen,M.,et al, 1992

The Molecular Pathogenesis of Alzheimer's Disease:Clinical Prospects
Lancet 340:1512-1515, Murphy,M., 1992

BA4 Amyloid Protein Deposition in Brain After Head Trauma
Lancet 338:1422-1423, Roberts,G.W.,et al, 1991

Cranial Neuropathy Associated with Primary Amyloidosis
Ann Neurol 29:451-454, Traynor,A.E.,et al, 1991

Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's Disease
NEJM 320:1446-1452, 1484-14861989., Rumble,B.,et al, 1989

Gerstmann-Straussler-Scheinker Disease, I, Extending the Clinical Spectrum
Neurol 39:1446-1452, Farlow,M.R.,et al, 1989

Gerstmann-Straussler-Scheinker Disease, II, Neurofibrillary Tangles & Plaques with PrP-amyloid in an Affected Family
Neurol 39:1453-1461, Ghetti,B.,et al, 1989

Clinical, Path, & Neurochem Changes in Dementia:Subgroup with Preserved Mental Status & Neocortical Plaques
Ann Neurol 23:138-144, Katzman,R.,et al, 1988

Dementia in Down's Syndrome:Cerebral Glucose Utilization, Neuropsychological Assessment, and Neuropathology
Neurol 38:938-942, Schapiro,M.B.,et al, 1988

Aluminium, Chemical Physiology and Alzheimer's Disease
Lancet 2:1008-1010, Birchall,J.D.&Chappell,J.S., 1988

Clinico-Pathologic Studies in Dementia:Nondemented Subjects with Pathologically Confirmed Alzheimer's Disease
Neurol 38:1682-1687, Crystal,H.,et al, 1988

Brain Amyloid and Alzheimer Disease
Ann Int Med 109:41-54, Vinters,H.V.,et al, 1988

Prions & Neurodegenerative Diseases
NEJM 317:1571-1581, 15971987., Prusiner,S.B., 1987

Mendelian Etiologies of Stroke
Ann Neurol 22:175-192, Natowicz,M.&Kelley,R.I., 1987

Gerstmann-Straussler-Scheinker Disease:Autopsy Study of a Familial Case
Ann Neurol 20:540-543, Vinters,H.V.,et al, 1986



Showing articles 50 to 100 of 1236 << Previous Next >>